Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal progesterone supplementation after IVF-ET
ACTRN12608000200381Phase 3Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of progesterone in infertility (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoints: Pregnancy rate after IVF-ET and Implantation rate after IVF-ET. Started Jan 2002; status: completed.
02
Drugs
progesterone
03
Conditions
infertility
Beyond the preview
Go deeper on ACTRN12608000200381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000200381.